Article
Upregulated osterix promotes invasion and bone metastasis and predicts for a poor prognosis in breast cancer
10 Jan 2019
Abstract excerpt
Approximately 70% of patients with advanced breast cancer develop bone metastases, accompanied by complications, such as bone pain, fracture, and hypercalcemia. However, our understanding of the molecular mechanisms that govern this process remains fragmentary. Osterix (Osx) is a zinc finger-containing transcription factor essential for osteoblast differentiation and bone formation. Here, we identified the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
